PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Columbia Presbyterian Medical Center, New York

Nyack Hospital, Nyack

AccuMed Research Associates, Garden City

The Urological Institute of Northeastern New York, Albany

University of Pittsburgh, Pittsburgh

Georgetown University Medical Center, Washington D.C.

Washington Hospital Center, Washington D.C.

Franklin Square Hospital Center, Baltimore

Virginia Urology Center, Richmond

McGuire Research Institute, Richmond

The Urology Center, Greensboro

Charleston Cancer Center, Charleston

Midtown Urology, Atlanta

South Florida Medical Research, Aventura

Advanced Research Institute, New Port Richey

Urology Centers of Alabama, Homewood

Urology Associates Clinical Research, Nashville

Metropolitan Urology, Jeffersonville

Urologic Associates, PC, Davenport

Midwest Research Specialists, LLC, Milwaukee

Medical College of Wisconsin, Milwaukee

Prairie Medical Associates, Ltd., Chicago

Medical and Surgical Specialists, Galesburg

OSF Saint Francis Medical Center, Peoria

Carle Clinic Cancer Center, Urbana

Urology Clinic of North Texas, PA, Dallas

Arlington Cancer Center, Arlington

Texas Cancer Care, Weatherford

Texas Cancer Center, Fort Worth

UCHSC Anschutz Cancer Pavilion, Aurora

Wyoming Research Foundation, Inc., Cheyenne

North Idaho Urology, Coeur d'Alene

Salt Lake Research, Salt Lake City

Urology Group of New Mexico, Albuquerque

Pacific Clinical Research, Santa Monica

Western Clinical Research, Inc., Torrance

Atlantic Urology Medical Group, Long Beach

San Diego Urology Center, La Mesa

Loma Linda University, Loma Linda

Urology Associates of Central California, Fresno

Alaska Clinical Research Center, Anchorage

Connecticut Clinical Research Center, Waterbury

Beth Israel Deaconess Medical Center, Boston

University of Nebraska Medical Center, Omaha

Lawrenceville Urology, Lawrenceville

The Cancer Institute of New Jersey, New Brunswick

University of Vermont, South Burlington